(5/11, Burba) reports researchers found “lymph node status is a predictor of survival in patients with vulvar melanoma [VuM] and vaginal melanoma [VaM].” The study’s authors said, “Lymph node status and mitotic rate are the most important predictors for disease-specific survival. Lymph node status should be assessed in all applicable patients with VuM and VaM. Those with positive lymph nodes may be candidates for adjuvant treatment.” The findings were published in American Journal of Clinical Dermatology.